Driving Our Children into Suicide with Escitalopram and Other Happy Pills
Mad In America,
In May 2023, FDA’s package insert for Lexapro (escitalopram) was updated. The drug can be used for depression in children from…
In May 2023, FDA’s package insert for Lexapro (escitalopram) was updated. The drug can be used for depression in children from…
In the face of the COVID pandemic, social and academic pressures, and an uncertain future, young people are struggling. Each…
Frontiers in Psychiatry publicó el año pasado un compendio especial de nueve artículos que analizan la evidencia, beneficios y…
A global campaign has been launched in the British Medical Journal to start to build an evidence base for healthcare that is…
A team of Polish researchers published a study following up on Irving Kirsch’s landmark 1998 piece ‘Listening to Prozac but…
When I was training to be a child psychiatrist in the mid-1990s, childhood depression was considered to be rare, related to…
Four years ago, the US National Institutes of Health (NIH) launched a pilot project to “leverage the social power of the…
Drug thought safe for teenagers linked to suicidal and self-harming behaviours. • Try one of PsyBlog's ebooks, all written by…
On May 17, 2017, we learned that Chris Cornell of Soundgarden had reportedly committed suicide by hanging. His family reports…
About five years ago, as my own blogging life was beginning, I found John M. Nardo’s outstanding blog, www.1boringoldman. His…
Even meta-analyses are often unreliable.Continue reading on Pacific Standard »
Of 559 interventional trials in children, 19 percent were stopped early and 30 percent of completed trials remained unpublished…
CORRUPTION OF CLINICAL TRIALS REPORTS:A PROPOSALThere is a disconnection between the FDA’s drug approval process and the…
If you’ve read recent reports that state “US suicide rates surge to a 30 year high,” you might first justify the reality with…
The treasure trove: Annotated links to some relevant materials. My recent post at Mind the Brain, Study protocol violations…
An extraordinary, must-read article is now available open access: Jureidini, JN, Amsterdam, JD, McHenry, LB. The citalopram CIT-M…
One in a series of three blog posts about Pharma’s promotion of medication for treatment of depression in young children and…
The Reasoner is a monthly digest highlighting exciting new research on reasoning, inference and method broadly construed. It is…
Those of you who read my last blog may remember that I talked about how upbeat friends can help boost your teenager’s mood. But…
“Thirdly, we will post the protocol of our trials as they are started and the results of trials once they are completed on two…
From the Ebola crisis to the weekend effect on hospital death rates, The BMJ publishes articles that receive extensive media…
Author's note: I was asked by the MHRA (Britain’s FDA) to give a 20-minute presentation on Spontaneous Reporting Systems to a…
Email from Fiona Godlee, Editor of the British Medical Journal (BMJ) to Restoring Invisible and Abandoned Trials (RIAT), July…
Last month was highly prolific in Alzheimer’s disease research – pathological mechanisms were described, detection tools were…
Here's a summary of popular BMJ content from August and September Most read from The…
In the late 1950s, perhaps because he was based partly in Rome, sensing a change in his native America, Gore Vidal warned that…
Revisiting clinical trial data has led investigators to conclude that not only was the antidepressant drug paroxetine is no…
Time to close down the breast cancer screening programme
Fourteen years after a drug trial had been published, investigators —using multiple sources, including regulatory and legal…
This past week saw the interestingly coincident publication of a reanalysis of “Study 329” in The BMJ and an opinion piece in…
Health and…
NEJM 17 Sep 2015 Vol…
Some of us may have heard of the problems with the data concerning SSRIs (a commonly used class of antidepressants) and, in…
“JJ had long known that something else was wrong with her — that no one should touch her blood. She had seen doctors every few…
This is extremely alarming http://t.co/gzLAPsYVRN — Paul Young (@DogICUma) September 18…
An anonymous reader writes: The NY Times is covering a new paper in the journal BMJ which re-analyzed data from a 2001 paper…
Well, this is no good: A new study published this week in The BMJ finds that the commonly prescribed antidepressant Paxil may…
This week the BMJ published an article written under the “Restoring invisible and abandoned trials initiative.” This 2013…
It’s not specific to the West Coast, but anyone who needs to catch up on the week’s events should read the British Medical…
A University of Adelaide led study has found that a psychiatric drug claimed to be a safe and effective treatment for…
by Craig Klugman, Ph.D. In an August 2015 Boston Globe opinion piece, Steven Pinker—professor of psychology at Harvard—wrote…
Good science is never defensive. No matter how strongly we believe something to be fact, we should always welcome challenges.
In 2001, a “landmark” study published in the prestigious Journal of the American Academy of Child and Adolescent Psychiatry…
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in…
Contrary to what a 2001 study found, the antidepressant drug Paxil is not safe and effective for teens. In fact, the very…
Health and…
In a major story, the New York Times presents the re-analysis by David Healy, Jon Jureidini, Mickey Nardo and others of Study…
Findings contradict those of the original analysis Related items from OnMedicaGSK to publish all clinical trials dataMPs demand…
The antidepressant Paxil isn’t safe or effective for teens after all, says a re-analysis of a 2001 study published today in The…
Experts who re-analysed data say study is still referred to in medical literature and needs to be retractedAn influential study…
Behind schedule again. RSS and e-mail readers, check back by 8:00 for completed Links, and one more post will also have…
I’m lucky enough to spend my workdays around the kinetic kids in Google Campus, London. From what I can tell, they sit about…